» Articles » PMID: 28777930

From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2017 Aug 5
PMID 28777930
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Phenotypes are rarely consistent across genetic backgrounds and environments, but instead vary in many ways depending on allelic variants, unlinked genes, epigenetic factors, and environmental exposures. In the extreme, individuals carrying the same causal DNA sequence variant but on different backgrounds can be classified as having distinct conditions. Similarly, some individuals that carry disease alleles are nevertheless healthy despite affected family members in the same environment. These genetic background effects often result from the action of so-called "modifier genes" that modulate the phenotypic manifestation of target genes in an epistatic manner. While complicating the prospects for gene discovery and the feasibility of mechanistic studies, such effects are opportunities to gain a deeper understanding of gene interaction networks that provide organismal form and function as well as resilience to perturbation. Here, we review the principles of modifier genetics and assess progress in studies of modifier genes and their targets in both simple and complex traits. We propose that modifier effects emerge from gene interaction networks whose structure and function vary with genetic background and argue that these effects can be exploited as safe and effective ways to prevent, stabilize, and reverse disease and dysfunction.

Citing Articles

In Search of Spinal Muscular Atrophy Disease Modifiers.

Chudakova D, Kuzenkova L, Fisenko A, Savostyanov K Int J Mol Sci. 2024; 25(20).

PMID: 39456991 PMC: 11508272. DOI: 10.3390/ijms252011210.


MDVarP: modifier ~ disease-causing variant pairs predictor.

Sun H, Chen Y, Ma L BioData Min. 2024; 17(1):39.

PMID: 39379981 PMC: 11460193. DOI: 10.1186/s13040-024-00392-y.


Genetic modifiers and ascertainment drive variable expressivity of complex disorders.

Jensen M, Smolen C, Tyryshkina A, Pizzo L, Banerjee D, Oetjens M medRxiv. 2024; .

PMID: 39252907 PMC: 11383473. DOI: 10.1101/2024.08.27.24312158.


VUS next in rare diseases? Deciphering genetic determinants of biomolecular condensation.

Heredia-Torrejon M, Montanez R, Gonzalez-Meneses A, Carcavilla A, Medina M, Lechuga-Sancho A Orphanet J Rare Dis. 2024; 19(1):327.

PMID: 39243101 PMC: 11380411. DOI: 10.1186/s13023-024-03307-6.


Exploring the Genotype-Phenotype Correlations in a Child with Inherited Seizure and Thrombocytopenia by Digenic Network Analysis.

Lu S, Niu Z, Qiao X Genes (Basel). 2024; 15(8).

PMID: 39202364 PMC: 11353731. DOI: 10.3390/genes15081004.


References
1.
. large-scale screening for targeted knockouts in the Caenorhabditis elegans genome. G3 (Bethesda). 2012; 2(11):1415-25. PMC: 3484672. DOI: 10.1534/g3.112.003830. View

2.
Noebels J . Pathway-driven discovery of epilepsy genes. Nat Neurosci. 2015; 18(3):344-50. PMC: 4852130. DOI: 10.1038/nn.3933. View

3.
Guy J, Hendrich B, Holmes M, Martin J, Bird A . A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet. 2001; 27(3):322-6. DOI: 10.1038/85899. View

4.
Lim J, Hao T, Shaw C, Patel A, Szabo G, Rual J . A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell. 2006; 125(4):801-14. DOI: 10.1016/j.cell.2006.03.032. View

5.
Youngren K, Coveney D, Peng X, Bhattacharya C, Schmidt L, Nickerson M . The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature. 2005; 435(7040):360-4. PMC: 1421521. DOI: 10.1038/nature03595. View